Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    March 2017
  1. BECKER DJ, Levy BP, Gold HT, Sherman SE, et al
    Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2017 Mar 15. doi: 10.1097/COC.0000000000000379.
    PubMed     Text format     Abstract available


    June 2016
  2. DEEK MP, Kim S, Ahmed I, Fang BS, et al
    Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  3. RAGHUNATHAN R, Cease K, Troeschel S, Zhao L, et al
    Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  4. MAQUILAN G, Grover S, Xanthopoulos E, Evans TL, et al
    Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  5. SMALL W JR, James JL, Moore TD, Fintel DJ, et al
    Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  6. CHOI YW, Jeon SY, Jeong GS, Lee HW, et al
    EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  7. BUCHBINDER EI, Desai A
    CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.
    Am J Clin Oncol. 2016;39:98-106.
    PubMed     Text format     Abstract available


    January 2016
  8. HAQUE W, Szeja S, Tann A, Kalra S, et al
    Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis.
    Am J Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  9. LANNI TB JR, Stevens C, Farah M, Boyer A, et al
    Early Results From the Implementation of a Lung Cancer Screening Program: The Beaumont Health System Experience.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  10. HONG J, Liao Z, Zhuang Y, Levy LB, et al
    Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  11. WANG EH, Corso CD, Park HS, Chen AB, et al
    Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  12. WAQAR SN, Waqar SH, Trinkaus K, Gadea CA, et al
    Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    August 2015
  13. JEREMIC B, Casas F, Dubinsky P, Cihoric N, et al
    The Trimodality Treatment Approach in Stage III/pN2 Non-Small Cell Lung Cancer: "Usually Appropriate" May Well be a Very Inappropriate Treatment Option.
    Am J Clin Oncol. 2015.
    PubMed     Text format    


  14. CRUZ-RICO G, Aviles-Salas A, Segura-Gonzalez M, Espinosa-Garcia AM, et al
    Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  15. OTANI S, Hamada A, Sasaki J, Wada M, et al
    Phase I and Pharmacokinetic Study of Erlotinib Administered in Combination With Amrubicin in Patients With Previously Treated, Advanced Non-small Cell Lung Cancer.
    Am J Clin Oncol. 2015;38:405-10.
    PubMed     Text format     Abstract available


  16. PILLAI K, Pourgholami MH, Chua TC, Morris DL, et al
    Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma.
    Am J Clin Oncol. 2015;38:388-94.
    PubMed     Text format     Abstract available


  17. MULHERIN BP, Brames MJ, Einhorn LH
    Long-term survival with paclitaxel and gemcitabine for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
    Am J Clin Oncol. 2015;38:373-6.
    PubMed     Text format     Abstract available


    July 2015
  18. TANG C, Lee MS, Gomez D, Levy LB, et al
    Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
    Am J Clin Oncol. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: